The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism.
Open accessAbstract
The renin-angiotensin system regulates normal cardiovascular homeostasis and is activated in certain forms of hypertension and in heart failure.Angiotensin II has multiple physiological effects and we have shown recently that its growth-promoting effects on vascular smooth muscle require autocrine activation of the IGF I receptor.To study the effect of angiotensin II on circulating IGF I, we infused rats with 500 ng/kg/min angiotensin II for up to 14 d.Angiotensin II markedly reduced plasma IGF I levels (56 and 41% decrease at 1 and 2 wk, respectively) and IGF binding protein-3 levels, and increased IGF binding protein-2 levels, a pattern suggestive of dietary restriction.Compared with sham, angiotensin II-infused hypertensive rats lost 18-26% of body weight by 1 wk, and pair-feeding experiments indicated that 74% of this loss was attributable to a reduction in food intake.The vasodilator hydralazine and the AT 1 receptor antagonist losartan had comparable effects to reverse angiotensin II-induced hypertension, but only losartan blocked the changes in body weight and in circulating IGF I and its binding proteins produced by angiotensin II.Moreover, in Dahl rats that were hypertensive in response to a high-salt diet, none of these changes occurred.Thus, angiotensin II produces weight loss through a pressor-independent mechanism that includes a marked anorexigenic effect and an additional (likely metabolic) effect.These findings have profound implications for understanding the pathophysiology of conditions, such as congestive heart failure, in which the renin-angiotensin system is activated.( J. Clin.Invest.1996.97:2509-2516.)Key words: congestive heart failure • hypertension • IGF binding proteins • metabolism • receptors, growth factor Methods Animals.We performed studies using male Sprague-Dawley rats of 290-360 grams obtained from Harlan Laboratories (Prattville, AL).Animals were housed in individual cages under standard conditions.Three experiments were performed, each consisting of different animal groups (n Ն 4 per group per time point), all involving the implan-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ahmed, A., Jorna, T., & Bhandari, S. (2016) · Nephron · doi:10.1159/000447068 · Cited by 11,717
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Insulin-Like Growth Factors and Their Binding Proteins: Biological Actions*
JONES, J. I., & CLEMMONS, D. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-1-3 · Cited by 4,710
Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
(1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271003 · Cited by 3,725
Cohn, J. N., Johnson, G., Ziesche, S., Cobb, F., Francis, G., Tristani, F., Smith, R., Dunkman, W. B., Loeb, H., Wong, M., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250502 · Cited by 2,833 · cited 1×
“In this regard, it is interesting to note that ACE inhibitors profoundly reduce cardiovascular mortality and morbidity in patients with heart failure, clearly more so than other vasodilators (58).”
BackgroundFort, P., Marty, L., Piechaczyk, M., Sabrouty, S. E., Dani, C., Jeanteur, P., & Blanchard, J. M. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.5.1431 · Cited by 2,099
Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans, P. B., Wong, P. C., Chiu, A. T., Herblin, W. F., Benfield, P., Carini, D. J., Lee, R. J., Wexler, R. R., Saye, J. A., & Smith, R. D. (1993) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00446-6 · Cited by 1,853
Nutritional Regulation of the Insulin-Like Growth Factors*
THISSEN, J.-P., KETELSLEGERS, J.-M., & UNDERWOOD, L. E. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-1-80 · Cited by 1,579
Nutritional regulation of the insulin-like growth factors
Thissen, J. P. (1994) · Endocrine Reviews · doi:10.1210/er.15.1.80 · Cited by 1,578
Sadoshima, J., & Izumo, S. (1993) · Circulation Research · doi:10.1161/01.res.73.3.413 · Cited by 1,427
Essential Hypertension: Renin and Aldosterone, Heart Attack and Stroke
Brunner, H. R., Laragh, J. H., Baer, L., Newton, M. A., Goodwin, F. T., Krakoff, L. R., Bard, R. H., & Bühler, F. R. (1972) · New England Journal of Medicine · doi:10.1056/nejm197203022860901 · Cited by 1,093
Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
Powell, J. S., Clozel, J.-P., Müller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., & Baumgartner, H. R. (1989) · Science · doi:10.1126/science.2526370 · Cited by 1,052
Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall.
Daemen, M. J., Lombardi, D. M., Bosman, F. T., & Schwartz, S. M. (1991) · Circulation Research · doi:10.1161/01.res.68.2.450 · Cited by 737
Alderman, M. H., Madhavan, S., Ooi, W. L., Cohen, H., Sealey, J. E., & Laragh, J. H. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104183241605 · Cited by 730
THEACUTEINFARCTIONRAMIPRILEFFI (1993) · The Lancet · doi:10.1016/0140-6736(93)92693-n · Cited by 547
Pathophysiology of chronic heart failure
Packer, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)90405-r · Cited by 473
Brain and Pituitary Angiotensin
SAAVEDRA, J. M. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-2-329 · Cited by 466
Blantz, R. C., Konnen, K. S., & Tucker, B. J. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108293 · Cited by 428
Radioimmunoassay for insulin-like growth factor-I: solutions to some potential problems and pitfalls
Breier, B. H., Gallaher, B. W., & Gluckman, P. D. (1991) · Journal of Endocrinology · doi:10.1677/joe.0.1280347 · Cited by 415
Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts.
Schorb, W., Booz, G. W., Dostal, D. E., Conrad, K. M., Chang, K. C., & Baker, K. M. (1993) · Circulation Research · doi:10.1161/01.res.72.6.1245 · Cited by 391
Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism.
Griffin, S. A., Brown, W. C., MacPherson, F., McGrath, J. C., Wilson, V. G., Korsgaard, N., Mulvany, M. J., & Lever, A. F. (1991) · Hypertension · doi:10.1161/01.hyp.17.5.626 · Cited by 391
Cardiac myocyte necrosis induced by angiotensin II.
Tan, L. B., Jalil, J. E., Pick, R., Janicki, J. S., & Weber, K. T. (1991) · Circulation Research · doi:10.1161/01.res.69.5.1185 · Cited by 384
Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells
Baker, K. M., & Aceto, J. F. (1990) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1990.259.2.h610 · Cited by 353
Control of sodium excretion by angiotensin II: intrarenal mechanisms and blood pressure regulation
Hall, J. E. (1986) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1986.250.6.r960 · Cited by 283
Fryburg, D. A., Jahn, L. A., Hill, S. A., Oliveras, D. M., & Barrett, E. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118217 · Cited by 254
Angiotensin II Induces Cardiac Phenotypic Modulation and Remodeling In Vivo in Rats
Kim, S., Ohta, K., Hamaguchi, A., Yukimura, T., Miura, K., & Iwao, H. (1995) · Hypertension · doi:10.1161/01.hyp.25.6.1252 · Cited by 246
Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat.
Crawford, D. C., Chobanian, A. V., & Brecher, P. (1994) · Circulation Research · doi:10.1161/01.res.74.4.727 · Cited by 229
Hormonal and Nutritional Regulation of IGF-I and Its Binding Proteins
Underwood, L. E., Thissen, J.-P., Lemozy, S., Ketelslegers, J.-M., & Clemmons, D. R. (1994) · Hormone Research · doi:10.1159/000184187 · Cited by 226
Nutritional regulation of insulin-like growth factor-I
Ketelslegers, J.-M., Maiter, D., Maes, M., Underwood, L. E., & Thissen, J.-P. (1995) · Metabolism · doi:10.1016/0026-0495(95)90221-x · Cited by 217
Insulin-like growth factor I and its binding proteins in the cardiovascular system
DELAFONTAINE, P. (1995) · Cardiovascular Research · doi:10.1016/0008-6363(95)00163-8 · Cited by 216
Self-citationThe Pathogenesis of Cardiac Cachexia.
(1966) · Annals of Internal Medicine · doi:10.7326/0003-4819-64-2-481_1 · Cited by 210
Angiotensin II Stimulation of Left Ventricular Hypertrophy in Adult Rat Heart
Baker, K. M., & Dostal, D. E. (1992) · American Journal of Hypertension · doi:10.1093/ajh/5.5.276 · Cited by 203
Carr, J. G., Stevenson, L. W., Walden, J. A., & Heber, D. (1989) · The American Journal of Cardiology · doi:10.1016/0002-9149(89)90256-7 · Cited by 202
The Pathogenesis of Cardiac Cachexia
Pittman, J. G., & Cohen, P. (1964) · New England Journal of Medicine · doi:10.1056/nejm196408202710807 · Cited by 202
Angiotensin stimulation of the central nervous system
Fitzsimons, J. T. (2005) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/bfb0030897 · Cited by 167
Donohue, T. J., Dworkin, L. D., Lango, M. N., Fliegner, K. H., Lango, R., Benstein, J. A., Slater, W., & Catanese, V. M. (1994) · Circulation · doi:10.1161/01.cir.89.2.799 · Cited by 151
Left ventricular insulin-like growth factor I increases in early renal hypertension.
Wåhlander, H., Isgaard, J., Jennische, E., & Friberg, P. (1992) · Hypertension · doi:10.1161/01.hyp.19.1.25 · Cited by 114
Regulation of insulin-like growth factor I messenger RNA levels in vascular smooth muscle cells.
Delafontaine, P., Lou, H., & Alexander, R. W. (1991) · Hypertension · doi:10.1161/01.hyp.18.6.742 · Cited by 109
Self-citationEffect of hypertension on fibronectin expression in the rat aorta.
Takasaki, I., Chobanian, A. V., Sarzani, R., & Brecher, P. I. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45828-0 · Cited by 93
Insulin-like growth factor I gene expression in vascular cells.
Delafontaine, P., Bernstein, K. E., & Alexander, R. W. (1991) · Hypertension · doi:10.1161/01.hyp.17.5.693 · Cited by 77
Self-citationAngiotensin II-induced thirst and vasopressin release in man
Phillips, P. A., Rolls, B. J., Ledingham, J. G. G., Morton, J. J., & Forsling, M. L. (1985) · Clinical Science · doi:10.1042/cs0680669 · Cited by 76
Delafontaine, P., Meng, X. P., Ku, L., & Du, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14383 · Cited by 66
Self-citationMinoxidil and the Treatment of Severe Hypertension
Koch‐Weser, J., & Pettinger, W. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010163031607 · Cited by 64
Converting enzyme inhibitors in cardiovascular therapy: current status and future potential
Unger, T., & Gohlke, P. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.2.146 · Cited by 60
Angiotensin II alters aortic fibronectin independently of hypertension.
Himeno, H., Crawford, D. C., Hosoi, M., Chobanian, A. V., & Brecher, P. I. (1994) · Hypertension · doi:10.1161/01.hyp.23.6.823 · Cited by 48
Angiotensin II increases cardiac protein synthesis in adult rat heart
Geenen, D. L., Malhotra, A., & Scheuer, J. (1993) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1993.265.1.h238 · Cited by 42
Crandall, D. L., Herzlinger, H. E., Saunders, B., Zolotor, R. C., Feliciano, L., & Cervoni, P. (1993) · Metabolism · doi:10.1016/0026-0495(93)90111-z · Cited by 40
Angiotensin II, aldosterone and arginine vasopressin in plasma in congestive heart failure
Pedersen, E. B., Danielsen, H., JENSEN, T., Madsen, M. G., Sørensen, S. S., & Thomsen, O. Ø. (1986) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1986.tb01308.x · Cited by 39
Subpressor angiotensin II is a bifunctional growth factor of vascular muscle in rats
Simon, G., & Altman, S. (1992) · Journal of Hypertension · doi:10.1097/00004872-199210000-00009 · Cited by 31
Angiotensin-induced hypertension in conscious dogs: biochemical parameters and baroreceptor reflex
Beck, A., Grasmugg, B., Singer, E. A., Bacher, S., & Raberger, G. (1985) · Cardiovascular Research · doi:10.1093/cvr/19.11.721 · Cited by 5
Minoxidil and the Treatment of Severe Hypertension
Pettinger, W. A. (1981) · Survey of Anesthesiology · doi:10.1097/00132586-198112000-00017 · Cited by 5
Cited by
Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy
Yoshida, T., & Delafontaine, P. (2020) · Cells · doi:10.3390/cells9091970 · Cited by 714
Self-citationLenk, K., Schuler, G., & Adams, V. (2010) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-010-0007-1 · Cited by 494
Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin System
Engeli, S., Negrel, R., & Sharma, A. M. (2000) · Hypertension · doi:10.1161/01.hyp.35.6.1270 · Cited by 475
The adipose-tissue renin–angiotensin–aldosterone system: role in the metabolic syndrome?
Engeli, S., Schling, P., Gorzelniak, K., Boschmann, M., Janke, J., Ailhaud, G., Teboul, M., Massiéra, F., & Sharma, A. M. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00311-4 · Cited by 415
Human angiotensin I-converting enzyme gene and endurance performance
Myerson, S., Hemingway, H., Budget, R., Martin, J., Humphries, S., Montgomery, H., & McGloin), (. T. T. A. O. M. M. A. H. (1999) · Journal of Applied Physiology · doi:10.1152/jappl.1999.87.4.1313 · Cited by 398
Metadata
- Authors
- Brink, M., Wellen, J., & Delafontaine, P.
- Venue
- Journal of Clinical Investigation
- Published
- 1996-06-01
- Volume
- 97
- Issue
- 11
- Pages
- 2509-2516
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2018431713
- Cited by
- 262
- References
- 54
- FWCI
- 4.92
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.